Newswise — ORLANDO, Fla. — Evidence continues to build that telomeres, cell endings that fray as we age, are affected by stress and are predictive of cancer risk. Scientists will present new groundbreaking research in this area of study at an AACR 102nd Annual Meeting 2011 press conference held on Saturday, April 2 at 2:00 p.m. ET in room W313 of the Orange County Convention Center.
AACR President Elizabeth H. Blackburn, Ph.D., the Morris Herzstein professor of biology and physiology in the department of biochemistry and biophysics at the University of California, San Francisco, will address the media on the role of telomeres.
Blackburn won the Nobel Prize in 2009 in Physiology or Medicine for her role in the discovery of telomerase, an enzyme that plays a key role in normal cell function, as well as in aging and most cancers. On Monday, April 4 at 12:30 p.m. ET she will become the immediate past-president of the American Association for Cancer Research.
Scott Lippman, M.D., chair of the department of thoracic/head and neck medical oncology at The University of Texas MD Anderson Cancer Center and editor-in-chief of Cancer Prevention Research, a journal of the American Association for Cancer Research, will moderate the press conference on the following research:
• Genetic Variation Linked to Longer Telomeres and Lower Risk of Bladder Cancer • Chronic Stress of Cancer Causes Accelerated Telomere Shortening
Reporters who cannot attend in person can participate by using the following information:
• U.S. & Canada: (888) 647-7462• International: (201) 604-0169• Access Code: 244081
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration
Follow the AACR on Twitter: @AACR #AACRFollow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
RSS